Rhumbline Advisers Sells 3,628 Shares of Intuitive Surgical, Inc. $ISRG

Rhumbline Advisers lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 672,703 shares of the medical equipment provider’s stock after selling 3,628 shares during the period. Rhumbline Advisers owned approximately 0.19% of Intuitive Surgical worth $300,853,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of ISRG. Tobam lifted its holdings in Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares in the last quarter. Kilter Group LLC acquired a new stake in Intuitive Surgical during the second quarter valued at $27,000. Princeton Global Asset Management LLC purchased a new position in Intuitive Surgical in the 2nd quarter valued at about $30,000. Greykasell Wealth Strategies Inc. acquired a new position in Intuitive Surgical during the third quarter worth $27,000. Finally, Riggs Asset Managment Co. Inc. increased its position in shares of Intuitive Surgical by 84.2% during the second quarter. Riggs Asset Managment Co. Inc. now owns 70 shares of the medical equipment provider’s stock valued at $38,000 after acquiring an additional 32 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 0.5%

Shares of NASDAQ:ISRG opened at $495.15 on Wednesday. The business has a 50 day moving average price of $546.68 and a 200 day moving average price of $510.62. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $609.08. The company has a market cap of $175.84 billion, a price-to-earnings ratio of 62.76, a PEG ratio of 3.83 and a beta of 1.65.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter in the previous year, the company posted $2.21 EPS. The business’s revenue for the quarter was up 18.8% compared to the same quarter last year. Analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insiders Place Their Bets

In related news, EVP Myriam Curet sold 230 shares of the firm’s stock in a transaction dated Tuesday, January 27th. The shares were sold at an average price of $532.61, for a total value of $122,500.30. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Gary S. Guthart sold 24,500 shares of Intuitive Surgical stock in a transaction on Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total value of $12,987,450.00. Following the sale, the director owned 3,694 shares in the company, valued at $1,958,189.40. This trade represents a 86.90% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 55,530 shares of company stock valued at $30,459,295 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. UBS Group reiterated a “neutral” rating on shares of Intuitive Surgical in a research report on Thursday, January 15th. TD Cowen upgraded Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. Rothschild & Co Redburn raised their price target on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Finally, Piper Sandler reissued an “overweight” rating and issued a $620.00 price target (up previously from $610.00) on shares of Intuitive Surgical in a report on Friday, January 23rd. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $617.23.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.